These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12654917)

  • 1. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells.
    Jallepalli PV; Lengauer C; Vogelstein B; Bunz F
    J Biol Chem; 2003 Jun; 278(23):20475-9. PubMed ID: 12654917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
    Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
    Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response.
    Ahn J; Urist M; Prives C
    J Biol Chem; 2003 Jun; 278(23):20480-9. PubMed ID: 12654916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells.
    Yu Q; Rose JH; Zhang H; Pommier Y
    FEBS Lett; 2001 Sep; 505(1):7-12. PubMed ID: 11557032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
    Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTK/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68.
    Wei JH; Chou YF; Ou YH; Yeh YH; Tyan SW; Sun TP; Shen CY; Shieh SY
    J Biol Chem; 2005 Mar; 280(9):7748-57. PubMed ID: 15618221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.
    Carrassa L; Broggini M; Erba E; Damia G
    Cell Cycle; 2004 Sep; 3(9):1177-81. PubMed ID: 15326376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific regulation of checkpoint kinase 2 expression by p53.
    Chin MY; Li G
    Exp Mol Pathol; 2003 Oct; 75(2):131-6. PubMed ID: 14516774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
    Falck J; Lukas C; Protopopova M; Lukas J; Selivanova G; Bartek J
    Oncogene; 2001 Sep; 20(39):5503-10. PubMed ID: 11571648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase.
    Rainey MD; Black EJ; Zachos G; Gillespie DA
    Oncogene; 2008 Feb; 27(7):896-906. PubMed ID: 17684483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response.
    Freiberg RA; Hammond EM; Dorie MJ; Welford SM; Giaccia AJ
    Mol Cell Biol; 2006 Mar; 26(5):1598-609. PubMed ID: 16478982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.
    Jack MT; Woo RA; Hirao A; Cheung A; Mak TW; Lee PW
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9825-9. PubMed ID: 12097646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
    Chehab NH; Malikzay A; Appel M; Halazonetis TD
    Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 53BP1, a mediator of the DNA damage checkpoint.
    Wang B; Matsuoka S; Carpenter PB; Elledge SJ
    Science; 2002 Nov; 298(5597):1435-8. PubMed ID: 12364621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest.
    Wang XQ; Stanbridge EJ; Lao X; Cai Q; Fan ST; Redpath JL
    Radiat Res; 2007 Dec; 168(6):706-15. PubMed ID: 18088187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 down-regulates CHK1 through p21 and the retinoblastoma protein.
    Gottifredi V; Karni-Schmidt O; Shieh SS; Prives C
    Mol Cell Biol; 2001 Feb; 21(4):1066-76. PubMed ID: 11158294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
    Zhao H; Traganos F; Darzynkiewicz Z
    Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.